NQO1, NAD(P)H quinone dehydrogenase 1, 1728

N. diseases: 368; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.070 AlteredExpression disease BEFREE And the distinct upregulated expressions of GCLC and NQO1 of HT-29 were detected after treatment with combinations compared to those of single ones. 31018491 2019
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.070 Biomarker disease BEFREE These results strongly suggest that NQO1 plays a significant role in preventing the development of colon cancer, and individuals with an NQO1 *2/*2 genotype are at an increased risk of developing this disease. 17164365 2006
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.070 GeneticVariation disease BEFREE This observation may suggest a protective role of the NQO1 wild-type allele in colon cancer susceptibility of individuals exposed to NQO1-inducing chemicals. 10663383 2000
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.070 AlteredExpression disease BEFREE RH1 was, correspondingly, more cytotoxic to human tumor cells expressing elevated NQO1 activity (H460 NSCLC and HT29 human colon carcinoma), as measured by 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium assay, than it was to cells deficient in NQO1 activity (H596 NSCLC and BE human colon carcinoma). 9865924 1998
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.070 AlteredExpression disease BEFREE We have previously characterized a homozygous point mutation in the BE human colon carcinoma cell line that leads to a loss of NQO1 activity. 9000600 1997
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.070 Biomarker disease BEFREE These results suggest that NQO1 may not have a role in EA resistance of human colon carcinoma HT29 cells and that EA is an inhibitor of NQO1 activity. 8010986 1994
CUI: C0699790
Disease: Colon Carcinoma
Colon Carcinoma
0.070 AlteredExpression disease BEFREE We studied 10 colon carcinoma cell lines showing different levels of DTD activity (range, 0-3447 nmol/min/mg protein), as measured by the reduction of dichlorophenolindophenol. 1737339 1992